Groundbreaking aerosol drug delivery
Aerogen Solo delivers more effective and controlled treatment, lowering risk of exposure. The Aerogen Solo delivers more inhaled medication to the lungs⁴, in less time ⁵, with less residual volume,7 compared to jet nebulizers, giving confidence in a more effective and controlled treatment.
The medication reservoir is isolated from the breathing circuit which minimizes nebulization of contaminated fluids¹. The risk of exposure to bioaerosols is reduced because the need to open the circuit is eliminated⁸.
The Aerogen Solo delivers more effective medication throughout the hospital through mechanical ventilation and non-invasive support such as non-invasive ventilation (NIV), high flow therapies (HFNC) and spontaneously breathing patients¹⁻⁷.
The Aerogen Solo is uniquely designed remaining in place during ventilation⁸. This closed system requires minimal management and can be left inline reducing staff handling and workload⁷ ¹⁰. Easy to set up and virtually silent operation, with no added flow required⁷.
… 6x more medication for spontaneously breathing patients4 than a traditional jet nebulizer in six healthy subjects. Pulmonary aerosol deposition was increased with the Aerogen Solo as compared with the jet nebulizer (34.1 ± 6.0% versus 5.2 ± 1.1%, p < 0.001).4
The Aerogen Ultra in combination with the Aerogen Solo provides faster and improved patient response by delivering more medication, in less time compared to traditional nebulization¹⁰ ¹¹ ¹². The Aerogen Ultra has been shown to reduce the number of treatments required for symptom control⁴ ¹⁰ leading to higher discharge rates and lower admission rates, all compared to traditional jet nebulization⁴ ¹⁰ ¹⁹.
Compared to traditional jet nebulization, Aerogen delivers:
• More inhaled medication delivered to the lung in nearly half the time in a COPD model¹².
• 85% of patients achieve symptom control with one 2.5mg salbutamol dose¹⁰.
• 37-minute median reduction in ED length of stay¹⁰.
Aerogen is the only closed-circuit aerosol drug delivery system that mitigates the transmission of patient-generated infectious aerosol¹ ².
Aerogen effectively delivers inhalation medication² ³ ⁴. With 5x more medication delivered to the lungs¹⁴ compared to a jet nebulizer¹⁵ and higher inhaled mass in an adult mechanical ventilation model with Aerogen compared to pMDI¹⁶.
Aerogen is recommended for use by many of the world’s leading mechanical ventilation companies including Dräger, GE, Hamilton Medical, Maquet, Medtronic, and Philips.
¹² ¹² ¹²
¹⁰ ¹¹ ¹²³ ⁰⁴ ⁵ ⁶ ⁷ ⁸⁹
Multiple clinical studies have demonstrated that Aerogen improves clinical outcomes in both pediatric and adult patients decreasing admission rates⁴ ¹⁰, providing better and faster symptom.4 and bronchodilator response⁴ ⁵ ¹⁰, all compared to the traditional jet nebulizer⁶ ⁷ ¹¹ ¹⁹. Nearly⁴ times more medication delivered to the lungs via NIV and HFNC, compared to a jet nebulizer¹⁶ ¹⁷ ¹⁸.
To meet the needs of the patient’s treatment, the Aerogen Solo delivers inhaled medication easily integrated into multiple respiratory systems⁹ ¹⁴ ²¹. As a single patient use device, the Aerogen Solo can be used for up to 28 days⁹ across multiple therapies, delivering optimal lung deposition¹⁶ ¹⁷ ¹⁸.
Fewer treatments, faster discharge, decrease in admissions, improved outcomes, decreased admission rates for pediatric patients under emergency care compared to the jet nebulizer⁴ ¹⁹.
With control and consistency of treatment critical during ventilation, the Aerogen Solo maintains a closed ventilation circuit with a medication reservoir positioned above the circuit and the medication reservoir is isolated from the patient circuit⁹ which enables drug delivery without breaking the circuit and minimizes nebulization of contaminated fluids⁹ ¹³and the associated risk of de-recruitment of the lungs²².
Service is essential to keep medical equipment operational and safe. Our Nordic service team consists of experienced service technicians stationed across the Nordic countries. Our service technicians are ready to take on your every service need.”
Nasal PAP ventilation system
The SuperNO2VA nasal PAP ventilation system uses the flow from any oxygen source. Delivers positive airway pressure to stent open the upper airway, allowing for the preoperative delivery of positive pressure ventilation and oxygen for patients with a decreased level of consciousness. The SuperNO2VA™ nasal PAP ventilation device is available in medium and large sizes and is offered as a standalone mask with a head strap and as a system, kitted with a hyperinflation bag. These configurations offer flexibility as it allows the SuperNO2VA™ nasal PAP ventilation device to be used with either an anesthesia machine or with only an oxygen flow meter.
The compact and intuitive AG CUFFILL device is the most accurate solution for measuring both pressure and volume of tracheal cuffs in all conditions. Its pocket-size, syringe-like design allows a simple and easy operation by medical professionals, including first-responders and hospital staff, and by users in the home care environment.
Key Features
Innovative phototherapy cover made of a high-tex material
BiliCap® is made of a 3-layered functional specialty knit fabric. A highly elastic, breathable membrane in the core assures the phototherapy cover’s imperviousness to light. The 3D knit spacing fabric underneath ensures optimum noise attenuation, provides an anti-slip effect and permanently retains the cover’s shape.
Additionally, the material is characterised by low weight and contains an active substance with permanently antimicrobial effect.
BiliCap® optimally shields the surrounding treatment places against the high light intensity while providing fast and flexible access via 4 side and 2 head/foot flaps. The one-size design allows flexible use, fitting all incubator models commonly available on the market. BiliCap® is certified according to Oeko-Tex® Standard 100, washable up to 95 °C and suitable for tumble-drying. Guaranteed permanence of function and colour even in the case of frequent laundering. Available in 2 colours with individual ornaments and embroidery.
Reliable respiration monitoring
The SISS BABYCONTROL monitors respiration of babies and infants and can thus provide reliable assistance against «Sudden Infant Death». High reliability, simple operation and convenient size make the SISS BABYCONTROL® a universally applicable instrument for baby monitoring in hospitals or at home.
Being prepared
Still today, “Sudden Infant Death” is an unforeseeable occurrence. 80% of the affected infants are entirely healthy beforehand. Only 20% are from so-called risk groups (former premature births or babies already suffering from life-threatening conditions or with a «Sudden Infant Death» among close relatives). Only a prompt alarm in the event of irregularities provides the chance to apply life-saving measures within the shortest possible time. Such measures should be learned beforehand in special courses.
